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Abnormal hair development and
regeneration has been implicated in
diseases of the skin (e.g., hirsutism,
alopecia) and in open wounds when
hair follicles are eliminated completely.
To manage these clinical conditions,
it is important to understand molecu-
lar pathways that regulate the num-
ber, size, growth, and regeneration of
hair follicles. Wnt signaling has a
fundamental role in this process. We
need a deeper understanding so that
we can reliably adjust Wnt levels in
existing follicles. In sum, the studies
reviewed here have future transla-
tional value for skin regeneration fol-
lowing severe wound injury and in
the context of tissue engineering.
Tuning the levels of Wnt ligands can
modulate the number and growth of
hairs directly. On the basis of this new
knowledge, we now know that Wnt
activity can be modulated by adjust-
ing the secretion of Wnt ligands,
altering binding of ligands to recep-
tors, inhibiting b-catenin transloca-
tion, or by regulating extrafollicular
dermal Wnt and Wnt inhibitors.
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TGFb1, an Epidermal Controller of Skin
Dendritic Cell Homeostasis
Akihiko Kitoh1, Takashi Nomura1 and Kenji Kabashima1
Transforming growth factor-b1 (TGFb1) is generally regarded as an anti-inflam-
matory cytokine. However, previous studies suggest that TGFb1 can promote
immune responses under certain conditions. In this issue, Mohammed et al. report
that epidermal keratinocyte-derived TGFb1 alone can alter homeostasis of multi-
ple cutaneous dendritic cell (DC) subsets, which may enhance skin inflammation.
These findings may provide a better understanding of the pathogenesis of
inflammatory skin disorders such as psoriasis, although how keratinocyte-derived
TGFb1 regulates cutaneous DCs under physiological and inflammatory conditions
should be further addressed.
Journal of Investigative Dermatology (2013) 133, 9–11. doi:10.1038/jid.2012.411
Transforming growth factor-b (TGFb)
is involved in a variety of biological
processes, such as embryogenesis,
morphogenesis, tissue repair, tumori-
genesis, and inflammation (Blobe
et al., 2000; Li et al., 2006; Rubtsov
and Rudensky, 2007). Of its three
isoforms, the immunological func-
tions of TGFb1 are relatively well
characterized. TGFb1 is generally
regarded as an anti-inflammatory
cytokine. For example, Tgfb1-deficient
mice and mice with impaired TGFb
signaling in T cells develop aggressive
multiorgan inflammation, with massive
infiltration by lymphocytes and macro-
phages (Veldhoen and Stockinger,
2006). On the other hand, strepto-
coccal cell wall–induced arthritis in rats
is aggravated by local administration
of TGFb1 (Wahl, 1994), and over-
expression of TGFb1 in keratinocytes
causes severe skin inflammation (Liu
et al., 2001; Li et al., 2004; Han et al.,
2010), suggesting that TGFb1 can pro-
mote immune responses under certain
conditions. These seemingly parado-
xical phenomena can be explained, at
least in part, by a dichotomy in TGFb1
function. TGFb1, in the absence of IL-6,
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promotes the generation of Foxp3þ
regulatory T cells from naive CD4þ
T cells, whereas in the presence of IL-6,
it promotes the induction of IL-17-pro-
ducing helper T (Th17) cells (Bettelli
et al., 2006).
Intriguingly, recent studies have sug-
gested that skin inflammation induced
by TGFb1 is not solely dependent on
either T cells or the IL-17/IL-23 axis
(Fitch et al., 2009; Michaelis et al.,
2010), indicating that immune cells
other than Th17 cells modulate skin
inflammation through TGFb1. How-
ever, the models of chronic TGFb1
overexpression by keratinocytes that
were developed in these studies do not
easily allow identification of the direct
target of TGFb1.
TGFb1 alters the
homeostasis
of cutaneous DC
subsets uniquely.
In this issue of JID, Mohammed et al.
(2012) focused on the acute effects of
TGFb1 overexpression by keratino-
cytes on skin dendritic cells (DCs)
(Mohammed et al., 2012). They utilized
a doxycycline (Dox)-inducible system,
in which TGFb1 could be produced by
keratinocytes only when the transgenic
mice were fed chow containing Dox.
TGFb1 induction in the basal keratino-
cytes increased both numbers and
CD86 expression of plasmacytoid DCs
(pDCs) and CD207þCD103þ , CD207
CD103CD11bþ , and CD207
CD103CD11b dermal DCs (dDCs)
in skin-draining lymph nodes (SDLNs).
The dermis of TGFb1-overexpressing
mice contained more pDCs, CD207þ
CD103þ dDCs, and CD207CD11bþ
dDCs, but not CD207CD11b dDCs
(Figure 1a and b). The application of the
dye tetramethyl rhodamine iso-thiocya-
nate (TRITC) after TGFb1 induction
increased the numbers of TRITCþ
CD207 dDCs in SDLNs, and augmen-
ted the migration of TRITC-induced
Langerhans cells 72 hours post TRITC
treatment. The authors concluded that
elevated epidermal TGFb1 alone is suf-
ficient to alter homeostasis of multiple
cutaneous DC subsets and to enhance
DC migration. In addition, contact
hypersensitivity response (Egawa and
Kabashima, 2011; Egawa et al., 2011;
Honda et al., 2012) induced by DNFB
was enhanced by the transient induction
of TGFb1 during sensitization. These
results highlight a role for keratinocyte-
derived TGFb1 in DC trafficking and
in the initiation of skin inflammation.
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Figure 1. Dynamics of Langerhans cells (LCs) and dermal dendritic cells (dDCs). (a) Under the
steady state. Doxycycline-induced transforming growth factor-b1 (TGFb1) overexpression by keratinocytes
(KCs) under (b) noninflammatory conditions and (c) inflammatory conditions, such as DNFB or TRITC
applications. LN, lymph node.
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On the basis of the finding that the
homeostasis of dermal DCs can be
modulated by epidermal keratinocytes, it
is tempting to speculate that interac-
tion between the epidermis and DC may
be one of the mechanisms that integrates
the dermal immune system. Further
studies are necessary to understand how
this mechanism works under physiol-
ogical conditions and whether it fails in
certain skin disorders, such as psoriasis,
where the amount of TGFb1 is correlated
with the severity of the disease (Kallimanis
et al., 2009). Normalizing keratinocyte/
DC interplay through TGFb1 may be a
novel therapeutic approach for psoriasis
and related inflammatory skin diseases.
The study by Mohammed et al. (2012)
provides new insight into cutaneous bio-
logy. To further understand its signifi-
cance, it will be interesting to address
whether transient induction of TGFb1
has other effects, in addition to promo-
ting immune responses. As DNFB, which
Mohammed et al. used to induce contact
hypersensitivity, is a hapten with strong
immunogenicity, the enhanced response
in the presence of transient TGFb1 induc-
tion during sensitization could have been
influenced by the inflammatory cyto-
kine milieu (such as IL-1b and IL-18)
produced by DNFB-stimulated keratino-
cytes (Figure 1c). On the other hand, tran-
sient induction of TGFb1 in the absence
of inflammatory stimuli may induce tole-
rance to antigens. In addition, it is impor-
tant to ask why TGFb1 affects only certain
subsets of DC, and what the roles of each
DC subset are in the context of skin
inflammation. The effect of TGFb1 on
immune cells other than DCs, viz T cells,
B cells, and macrophages, is another
interesting issue that needs to be explored.
It should be noted that TGFb1 exerts
its function in a context-dependent man-
ner. Given that overexpression of TGFb1
by keratinocytes in vivo is likely to
occur under inflammatory conditions,
it would be useful to know how kerati-
nocyte-derived TGFb1 regulates skin
DCs under physiological conditions,
where the amount of TGFb1 is likely
to be much lower. Such knowledge will
provide a better understanding of the
pathogenesis of inflammatory skin dis-
orders, such as psoriasis. The mouse
model developed by Mohammed et al.
(2012) should be a very powerful tool
for clarifying the mysterious roles of
TGFb1 in other fields, such as embryo-
genesis, morphogenesis, tissue repair,
tumorigenesis, and inflammation.
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Cutaneous Pigmentation in Health and
Disease: Novel and Well-Established
Players
Mina Yaar1
Cutaneous pigment formation and aberration in disease are addressed. Dynoodt
et al. (this issue) present data on a specific micro RNA that downregulates proteins
involved in melanogenesis and melanosome movement. Kim et al. (this issue)
present data showing that Wnt signaling is involved in the pathogenesis of
melasma. Both articles enhance our understanding of cutaneous pigmentation
and point to targets in the development of novel therapeutic modalities.
Journal of Investigative Dermatology (2013) 133, 11–13. doi:10.1038/jid.2012.442
Melanin is a complex biopolymer that is
synthesized in melanocytes, stored in cyto-
plasmic organelles called melanosomes,
and provides protection against UV-
induced damage by absorbing and scat-
tering UV radiation (reviewed in Park
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